Georgia Regents Research Institute, Inc.

Georgia Health Sciences University Research Institute, Inc.

Wendy Bollinger Bollag

Xiaofeng Zhong

Xiangjian Zheng

Ding Xie

The disclosure is generally directed to methods and compositions for modulating keratinocyte function, more particularly, to compositions and methods for normalizing keratinocyte proliferation and differentiation, compositions and methods for modulating levels of phosphatidylglycerol (PG) in keratinocytes, and compositions and methods for treating skin conditions by modulating keratinocyte proliferation.

Methods and compositions for modulating keratinocyte function

The present invention provides a method of treating a corneal disorder comprising administering to a patient in need thereof a composition containing pharmaceutically effective amount of dioleoylphosphatidylglycerol and/or palmitoyloleoylphosphatidylglycerol and a pharmaceutically acceptable carrier.

Growing community of inventors

Martinez, GA, United States of America

Wendy Bollinger Bollag